Reply to S. Takamizawa et al

J Clin Oncol. 2020 Aug 10;38(23):2700-2701. doi: 10.1200/JCO.20.01190. Epub 2020 Jun 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Cisplatin*
  • Cyclophosphamide
  • Doxorubicin
  • Germ Cells
  • Humans
  • Neoadjuvant Therapy

Substances

  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin

Associated data

  • ClinicalTrials.gov/NCT01670500